CVOB560A12101: A phase 1b, multicenter study of VOB560 in combination with MIK665 in patients with relapsed/refractory non-hodgkin lymphoma, relapsed/refractory acute myeloid leukemia, or relapsed /refractory multiple myeloma

Principal investigator: Kimmo Porkka
HUS Helsinki University Hospital, Comprehensive Cancer Center